Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

MSCs help rejuvenate skin by promoting cell growth and reducing inflammation.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Anabolic steroids and SARMs can cause serious liver damage.

Targeting EGFR may help reduce hair loss from chemotherapy.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

The nanofibers with two growth factors improved wound healing by supporting structure, preventing infection, and aiding tissue growth.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

There is no significant link between male pattern baldness and insulin resistance.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Certain growth factors can promote hair growth in mice by activating hair growth-related proteins.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

FGF-2&D/P nanoparticles can help treat hair loss.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Lower growth factors linked to balding in androgenetic alopecia.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

AGA patients have higher heart disease risk.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.